BARDA provides additional $7.2M to OraSure for development of Ebola test

Separately, the HHS’ Centers for Disease Control and Prevention (CDC) will purchase ~$1.5M of OraQuick Ebola for field testing in West Africa. Full Article http://j.gs/5sTq

Click here to read full article